Bromodomain Protein Inhibitors Reorganize the Chromatin of Synovial Fibroblasts.

Krošel, Monika; Moser, Larissa; Houtman, Miranda; Friščić, Jasna; Tomšič, Matija; Distler, Oliver; Hoffmann, Markus H; Ospelt, Caroline; Klein, Kerstin (2023). Bromodomain Protein Inhibitors Reorganize the Chromatin of Synovial Fibroblasts. Cells, 12(8) MDPI 10.3390/cells12081149

[img]
Preview
Text
cells-12-01149.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (1MB) | Preview

Bromodomain- and extra-terminal domain (BET) proteins are epigenetic reader proteins that regulate transcription of their target genes by binding to acetylated histone side chains. Small molecule inhibitors, such as I-BET151, have anti-inflammatory properties in fibroblast-like synoviocytes (FLS) and in animal models of arthritis. Here, we investigated whether BET inhibition can also affect the levels of histone modifications, a novel mechanism underlying BET protein inhibition. On the one hand, FLSs were treated with I-BET151 (1 µM) for 24 h in absence and presence of TNF. On the other hand, FLSs were washed with PBS after 48 h of I-BET151 treatment, and the effects were measured 5 days after I-BET151 treatment or after an additional 24 h stimulation with TNF (5 d + 24 h). Mass spectrometry analysis indicated that I-BET151 induced profound changes in histone modifications, with a global reduction in acetylation on different histone side chains 5 days after treatment. We confirmed changes on acetylated histone side chains in independent samples by Western blotting. I-BET151 treatment reduced mean TNF-induced levels of total acetylated histone 3 (acH3), H3K18ac, and H3K27ac. In line with these changes, the TNF-induced expression of BET protein target genes was suppressed 5 d after I-BET151 treatment. Our data indicate that BET inhibitors not only prevent the reading of acetylated histones but directly influence overall chromatin organization, in particular after stimulation with TNF.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Rheumatologie
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Rheumatologie

04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Rheumatology, Clinical Immunology and Allergology

UniBE Contributor:

Klein, Kerstin

Subjects:

600 Technology > 610 Medicine & health

ISSN:

2073-4409

Publisher:

MDPI

Language:

English

Submitter:

Pubmed Import

Date Deposited:

17 May 2023 13:59

Last Modified:

17 May 2023 14:08

Publisher DOI:

10.3390/cells12081149

PubMed ID:

37190058

Uncontrolled Keywords:

BET bromodomain protein I-BET chromatin organization histone acetylation

BORIS DOI:

10.48350/182631

URI:

https://boris.unibe.ch/id/eprint/182631

Actions (login required)

Edit item Edit item
Provide Feedback